Rod Kunynetz

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

Alice B. Gottlieb, Alan Menter, Alan M. Mendelsohn et al. · The Lancet · 2009 · 583 citations

Medicine, Clinical Sciences, Immunology +15

Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.

Carrie Brodmerkel, Eric Wadman, Richard G. Langley et al. · PubMed · 2013 · 69 citations

Life Sciences, Dermatology, Immunology +16

A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial

Yves Poulin, Néstor P. Sánchez, A Bucko et al. · British Journal of Dermatology · 2011 · 58 citations

Medicine, Dermatology, Pharmacotherapy +5

A Randomized, Double-Blind, Multicenter, Parallel Group Study to Compare Relative Efficacies of the Topical Gels 3% Erythromycin/5% Benzoyl Peroxide and 0.025% Tretinoin/Erythromycin 4% in the Treatment of Moderate Acne Vulgaris of the Face

Aditya K. Gupta, Charles Lynde, Rod Kunynetz et al. · Journal of Cutaneous Medicine and Surgery · 2003 · 31 citations

Medicine, Dermatology, Pharmacology +13

The occurrence of mycosis fungoides in two patients with preexisting Hodgkin's disease.

Michael Lipa, Rod Kunynetz, Danuta Pawlowski et al. · PubMed · 1982 · 18 citations

Medicine, Dermatology, Pathology +6